Peer-Reviewed Journal Details
Mandatory Fields
Browne, S,Monaghan, MG,Brauchle, E,Berrio, DC,Chantepie, S,Papy-Garcia, D,Schenke-Layland, K,Pandit, A
2015
November
Biomaterials
Modulation of inflammation and angiogenesis and changes in ECM GAG-activity via dual delivery of nucleic acids
Published
Altmetric: 1WOS: 17 ()
Optional Fields
Collagen Gene therapy Inflammation Angiogenesis Extracellular matrix (ECM) FOREIGN-BODY REACTION ENDOTHELIAL PROGENITOR CELLS EXTRACELLULAR-MATRIX IN-VIVO GROWTH-FACTOR FUNCTIONALIZED SCAFFOLD RAMAN MICROSPECTROSCOPY MACROPHAGE PHENOTYPE COLLAGEN GLYCOSAMINOGLYCANS
69
133
147
Tissue-engineered organs and implants hold promise for the replacement of damaged and diseased organs. However, the foreign body response (FBR) is a major obstacle that compromises the function of tissue-engineered constructs, typically causing them to fail. Two components of FBR are an inflammatory response and a lack of vascularization. To overcome these limitations, a collagen system was developed to release interleukin-6 (IL-6) siRNA and endothelial nitric oxide synthase (eNOS) pDNA in a staggered manner. Hollow collagen microspheres were assembled into a collagen sphere-in-hydrogel system that displayed a staggered release profile in vitro. This system was assessed in vivo in a subcutaneous rat model. The doses of IL-6 siRNA and eNOS pDNA were first individually optimized for their ability to reduce the volume fraction of inflammatory cells (7 days) and increase the length density of blood vessels (14 days), respectively. The identified optimal doses were combined, and the ability of the system to decrease the volume fraction of inflammatory cells and increase the length density of blood vessels was confirmed at both 7 and 14 days. Analysis of the tissue using Raman microspectroscopy revealed that in addition to changes in inflammation and angiogenesis, there were also changes in the extracellular matrix (ECM) at seven days. While changes in sulfated glycosaminoglycan (sGAG) content of the ECM were not detected, changes in the binding of sGAG of the ECM to growth factors were observed. Two growth factors tested, VEGF(165) and bFGF showed increased binding to sGAG extracted from eNOS pDNA-treated samples at seven days, increasing the angiogenic potential of the ECM. Thus, we observe that changes in the tissue in terms of the balance of inflammation and angiogenesis as well changes in the activity of sGAG of the ECM occurs following dual delivery of nucleic acids from the collagen sphere-in-hydrogel system. (C) 2015 Elsevier Ltd. All rights reserved.
10.1016/j.biomaterials.2015.08.012
Grant Details
Publication Themes